fura-2 has been researched along with Carcinoma, Transitional Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boergermann, C; Jakobs, KH; Lümmen, G; Rübben, H; Sanders, H; Schmidt, M; vom Dorp, F | 1 |
Huang, JK; Jan, CR; Yu, CC | 1 |
Chang, HT; Cheng, JS; Huang, JK; Jan, CR; Lee, KC; Lin, MC; Lo, YK; Tang, KY; Wang, JL | 1 |
3 other study(ies) available for fura-2 and Carcinoma, Transitional Cell
Article | Year |
---|---|
Inhibition of Rho-kinase abrogates migration of human transitional cell carcinoma cells: results of an in vitro study.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Amides; Bacterial Proteins; Bacterial Toxins; Calcium; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Fura-2; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Lysophospholipids; Mutation; Pertussis Toxin; Phalloidine; Protein Kinase Inhibitors; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; Type C Phospholipases | 2011 |
Dual effect of the antianginal drug fendiline on bladder female transitional carcinoma cells: mobilization of intracellular CA2+ and induction of cell death.
Topics: Anti-Arrhythmia Agents; Calcium; Carcinoma, Transitional Cell; Cell Death; Cell Survival; Dose-Response Relationship, Drug; Female; Fendiline; Fluorescent Dyes; Fura-2; Humans; Inositol 1,4,5-Trisphosphate; Time Factors; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2001 |
Tamoxifen-induced Ca2+ mobilization in bladder female transitional carcinoma cells.
Topics: Anticarcinogenic Agents; Calcium Signaling; Carcinoma, Transitional Cell; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrenes; Fluorescent Dyes; Fura-2; Humans; Pyrrolidinones; Tamoxifen; Thapsigargin; Tumor Cells, Cultured; Type C Phospholipases; Urinary Bladder Neoplasms | 2001 |